Marks JD - Search Results

1

Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.

Rudnick SI, Lou J, Shaller CC, Tang Y, Klein-Szanto AJ, Weiner LM, Marks JD, Adams GP. Rudnick SI, et al. Among authors: marks jd. Cancer Res. 2011 Mar 15;71(6):2250-9. doi: 10.1158/0008-5472.CAN-10-2277. Cancer Res. 2011. PMID: 21406401 Free PMC article.

2

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

Schier R, Bye J, Apell G, McCall A, Adams GP, Malmqvist M, Weiner LM, Marks JD. Schier R, et al. Among authors: marks jd. J Mol Biol. 1996 Jan 12;255(1):28-43. doi: 10.1006/jmbi.1996.0004. J Mol Biol. 1996. PMID: 8568873

3

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.

Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD. Schier R, et al. Among authors: marks jd, marks c. J Mol Biol. 1996 Nov 8;263(4):551-67. doi: 10.1006/jmbi.1996.0598. J Mol Biol. 1996. PMID: 8918938

4

In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.

Schier R, Marks JD, Wolf EJ, Apell G, Wong C, McCartney JE, Bookman MA, Huston JS, Houston LL, Weiner LM, et al. Schier R, et al. Among authors: marks jd. Immunotechnology. 1995 May;1(1):73-81. doi: 10.1016/1380-2933(95)00007-0. Immunotechnology. 1995. PMID: 9373335

5

Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.

Adams GP, Schier R, Marshall K, Wolf EJ, McCall AM, Marks JD, Weiner LM. Adams GP, et al. Among authors: marks jd. Cancer Res. 1998 Feb 1;58(3):485-90. Cancer Res. 1998. PMID: 9458094

6

Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu.

Adams GP, Schier R, McCall AM, Crawford RS, Wolf EJ, Weiner LM, Marks JD. Adams GP, et al. Among authors: marks jd. Br J Cancer. 1998 May;77(9):1405-12. doi: 10.1038/bjc.1998.233. Br J Cancer. 1998. PMID: 9652755 Free PMC article.

7

Characterization of anti-mouse Fc gamma RII single-chain Fv fragments derived from human phage display libraries.

McCall AM, Amoroso AR, Sautès C, Marks JD, Weiner LM. McCall AM, et al. Among authors: marks jd. Immunotechnology. 1998 Jun;4(1):71-87. doi: 10.1016/s1380-2933(98)00006-2. Immunotechnology. 1998. PMID: 9661816

8

Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.

McCall AM, Adams GP, Amoroso AR, Nielsen UB, Zhang L, Horak E, Simmons H, Schier R, Marks JD, Weiner LM. McCall AM, et al. Among authors: marks jd. Mol Immunol. 1999 May;36(7):433-45. doi: 10.1016/s0161-5890(99)00057-7. Mol Immunol. 1999. PMID: 10449096

9

Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules.

Adams GP, Shaller CC, Chappell LL, Wu C, Horak EM, Simmons HH, Litwin S, Marks JD, Weiner LM, Brechbiel MW. Adams GP, et al. Among authors: marks jd. Nucl Med Biol. 2000 May;27(4):339-46. doi: 10.1016/s0969-8051(00)00103-7. Nucl Med Biol. 2000. PMID: 10938467

10

Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.

Nielsen UB, Adams GP, Weiner LM, Marks JD. Nielsen UB, et al. Among authors: marks jd. Cancer Res. 2000 Nov 15;60(22):6434-40. Cancer Res. 2000. PMID: 11103810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters